These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31722863)

  • 1. [Aspergillus spondylodiscitis in a patient treated with ibrutinib].
    Petitdemange A; Martin A; Ruch Y; Chatron E; Karol A; Hansmann Y
    Med Mal Infect; 2020 May; 50(3):296-297. PubMed ID: 31722863
    [No Abstract]   [Full Text] [Related]  

  • 2. Ibrutinib as initial therapy in chronic lymphocytic leukemia: A systematic review and meta-analysis.
    Molica S; Giannarelli D; Baumann T; Montserrat E
    Eur J Haematol; 2020 May; 104(5):512-515. PubMed ID: 31957067
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral aspergillosis in a patient on ibrutinib therapy.
    Creuzet E; Nourrisson C; Chaleteix C; Poirier P; Moniot M
    Br J Haematol; 2021 Jun; 193(6):1025. PubMed ID: 33748950
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
    Anastasopoulou A; DiPippo AJ; Kontoyiannis DP
    Mycoses; 2020 Aug; 63(8):787-793. PubMed ID: 32458510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.
    Cuneo A; Mato AR; Rigolin GM; Piciocchi A; Gentile M; Laurenti L; Allan JN; Pagel JM; Brander DM; Hill BT; Winter A; Lamanna N; Tam CS; Jacobs R; Lansigan F; Barr PM; Shadman M; Skarbnik AP; Pu JJ; Sehgal AR; Schuster SJ; Shah NN; Ujjani CS; Roeker L; Orlandi EM; Billio A; Trentin L; Spacek M; Marchetti M; Tedeschi A; Ilariucci F; Gaidano G; Doubek M; Farina L; Molica S; Di Raimondo F; Coscia M; Mauro FR; de la Serna J; Medina Perez A; Ferrarini I; Cimino G; Cavallari M; Cucci R; Vignetti M; Foà R; Ghia P;
    Cancer Med; 2020 Nov; 9(22):8468-8479. PubMed ID: 32969597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis.
    Molica S; Baumann T; Giannarelli D
    Eur J Haematol; 2021 Mar; 106(3):425-427. PubMed ID: 33190324
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report.
    Le TH; Kumar V; Gondal K; Barnes M; Siddique H; Buttar B; Kaell A
    BMC Infect Dis; 2020 Feb; 20(1):175. PubMed ID: 32093604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study.
    Gentile M; Morabito F; Del Poeta G; Mauro FR; Reda G; Sportoletti P; Laurenti L; Coscia M; Herishanu Y; Recchia AG; Varettoni M; Murru R; Chiarenza A; Condoluci A; Moia R; Pietrasanta D; Loseto G; Consoli U; Scortechini I; Rossi FM; Zucchetto A; Fraticelli V; Vigna E; Botta C; Tripepi G; Arrigo G; Rago A; Angeletti I; Biagi A; Del Giudice I; Bomben R; Rigolin GM; Rossi D; Di Raimondo F; Gaidano G; Polliack A; Cuneo A; Foà R; Gattei V
    Leukemia; 2021 Jan; 35(1):235-238. PubMed ID: 32286543
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib.
    Aarup K; Rotbain EC; Enggaard L; Pedersen RS; Bergmann OJ; Thomsen RH; Frederiksen M; Frederiksen H; Nielsen T; Christiansen I; Andersen MA; Niemann CU
    Eur J Haematol; 2020 Nov; 105(5):646-654. PubMed ID: 32736410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibrutinib Treatment and EGFR-mutant Lung Adenocarcinoma.
    Shulman K; Kazarin O; Tannous E; Sofer O
    Isr Med Assoc J; 2021 Jun; 23(6):385-386. PubMed ID: 34155856
    [No Abstract]   [Full Text] [Related]  

  • 11. Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
    Rigolin GM; Del Giudice I; Bardi A; Melandri A; García-Jacobo RE; Cura F; Raponi S; Ilari C; Cafforio L; Piciocchi A; Arena V; Reda G; Albano F; Molica S; Sportoletti P; Trentin L; Marchetti M; Nanni M; Peragine N; Mariglia P; Vignetti M; Guarini A; Mauro FR; Foà R; Cuneo A
    Blood; 2021 Dec; 138(25):2727-2730. PubMed ID: 34587233
    [No Abstract]   [Full Text] [Related]  

  • 12. Spondylodiscitis Due to Aspergillus terreus in an Immunocompetent Host: Case Report and Literature Review.
    Comacle P; Le Govic Y; Hoche-Delchet C; Sandrini J; Aguilar C; Bouyer B; Blanchi S; Penn P
    Mycopathologia; 2016 Aug; 181(7-8):575-81. PubMed ID: 27038797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.
    Pleyer C; Tian X; Rampertaap S; Mu R; Soto S; Superata J; Gaglione E; Sun C; Lotter J; Stetler-Stevenson M; Yuan CM; Maric I; Pittaluga S; Rosenzweig S; Fleisher T; Wiestner A; Ahn IE
    Am J Hematol; 2020 Nov; 95(11):E310-E313. PubMed ID: 32808680
    [No Abstract]   [Full Text] [Related]  

  • 14. Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia.
    Kidoguchi K; Kubato Y; Nishimura Y; Kizuka-Sano H; Kimura S
    Turk J Haematol; 2021 Feb; 38(1):83-85. PubMed ID: 33161683
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.
    Wéclawiak H; Garrouste C; Kamar N; Linas MD; Tall P; Dambrin C; Durand D; Rostaing L
    Transplant Proc; 2007 Oct; 39(8):2627-8. PubMed ID: 17954195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibrutinib-Induced Skin Rash.
    Kirar S; Gogia A; Gupta R; Mallick S
    Turk J Haematol; 2021 Feb; 38(1):81-83. PubMed ID: 33053966
    [No Abstract]   [Full Text] [Related]  

  • 17. Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
    Vitale C; Salvetti C; Griggio V; Porrazzo M; Schiattone L; Zamprogna G; Visentin A; Vassallo F; Cassin R; Rigolin GM; Murru R; Laurenti L; Rivela P; Marchetti M; Pennese E; Gentile M; Boccellato E; Perutelli F; Montalbano MC; De Paoli L; Reda G; Orsucci L; Trentin L; Cuneo A; Tedeschi A; Scarfò L; Gaidano G; Mauro FR; Foà R; Boccadoro M; Coscia M
    Blood; 2021 Jun; 137(25):3507-3517. PubMed ID: 33651883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspergillus spondylodiscitis after multivisceral transplantation.
    Gerlach UA; Kohler S; Sauer IM; Joerres D; Kandziora F; Neuhaus P; Pratschke J; Pascher A
    Ann Transplant; 2009; 14(4):52-7. PubMed ID: 20009156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial.
    Sharman JP; Brander DM; Mato AR; Ghosh N; Schuster SJ; Kambhampati S; Burke JM; Lansigan F; Schreeder MT; Lunin SD; Zweibach A; Shtivelband M; Travis PM; Chandler JC; Kolibaba KS; Sportelli P; Miskin HP; Weiss MS; Flinn IW
    Lancet Haematol; 2021 Apr; 8(4):e254-e266. PubMed ID: 33631112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal discitis due to Aspergillus terreus in a patient with acute lymphoblastic leukemia.
    Park KU; Lee HS; Kim CJ; Kim EC
    J Korean Med Sci; 2000 Dec; 15(6):704-7. PubMed ID: 11194199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.